GCM
TECH icon

Graham Capital Management’s Bio-Techne TECH Stock Holding History

Graham Capital Management’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-9,949
Closed -$520K – 1501
2026
Q1 		$520K Sell
9,949
-2,536
-20% -$152K 0.01% 613
2025
Q4 		$734K Buy
+12,485
New +$759K 0.02% 480
2025
Q3 		– Sell
-6,243
Closed -$321K – 1638
2025
Q2 		$321K Buy
+6,243
New +$314K ﹤0.01% 974
2024
Q1 		– Sell
-2,840
Closed -$219K – 1298
2023
Q4 		$219K Sell
2,840
-17,061
-86% -$1.12M ﹤0.01% 816
2023
Q3 		$1.35M Buy
+19,901
New +$1.57M 0.03% 279
2023
Q2 		– Sell
-14,034
Closed -$1.04M – 1293
2023
Q1 		$1.04M Buy
14,034
+10,165
+263% +$783K 0.03% 489
2022
Q4 		$321K Buy
+3,869
New +$307K 0.01% 870
2022
Q3 		– Sell
-9,048
Closed -$784K – 1318
2022
Q2 		$784K Buy
+9,048
New +$848K 0.03% 516

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Graham Capital Management's TECH Position: Q2 2026 in Review

Graham Capital Management sold out of Bio-Techne (TECH) in Q2 2026, closing a stake of 9,949 shares — an estimated $520K sold.

Graham Capital Management first reported a position in TECH in Q2 2022 and held it in 8 quarters. The position peaked at $1.35M in Q3 2023. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Graham Capital Management reported no remaining Bio-Techne position as of Q2 2026 after selling out during the quarter.
  • Graham Capital Management sold 9,949 Bio-Techne shares in Q2 2026, an estimated $520K.
  • Graham Capital Management first reported a position in Bio-Techne in Q2 2022 and held it in 8 quarters.
  • Graham Capital Management's Bio-Techne position peaked at $1.35M in Q3 2023.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Graham Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.